A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search

July 2017 Formulary Changes to the Top Medicare Drugs

Category: Monthly Formulary Changes
Published: Jul, 17 2017 06:07:16


The July, 2017 Medicare Part D plan formulary (or drug list) data included 114 new drug codes or NDCs representing 70 different medications.

The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

This article highlights the change for some of the "top Medicare drugs", including their generic equivalents .  The generics included are Atorvastatin [Lipitor®] , Clopidogrel [Plavix®], Escitalopram [Lexapro®], Esomeprazole Sodium [Nexium®], Pioglitazone [Actos®], Risedronate Sodium [Actonel®], Quetiapine Fumarate [Seroquel®], and Valsartan-HCTZ [Diovan HCT®]. 

The changes to the number of formularies covering these medications looks as follows:

Count of 2017 Formularies covering the Top Medicare Drugs Program wide
    Formulary Count*
NDC Drug Name 2013 End** 2014 End** 2015 End** 2016 End** 2017 Start** April May June July Aug.
00430047203 ACTONEL 35 MG 36 DOSE PACK 233 248 148 25 11 11 11  11  11  
64764030115 ACTOS 30MG/1 TABLET (90 CT) 214 75 35 23 16 16 16  16  16  
00173069600 ADVAIR DISKUS MIS 250/50 307 347 353 348 358 362 363  363  363  
63304082790 ATORVASTATIN 10 MG TABLET [Lipitor] 316 364 394        
00378395009 ATORVASTATIN 10 MG TABLET [Lipitor] 385 377 379 380  380  380  
00378362777 CLOPIDOGREL TAB 75MG [Plavix] 315 364        
55111019630 CLOPIDOGREL TAB 75MG [Plavix] 394        
00093731456 CLOPIDOGREL TAB 75MG [Plavix] 385 377 379 380  380  380  
00078031534 DIOVAN HCT 160/12.5MG TABLET 185 80 50 29 21 21 21  21  21  
00093585101 ESCITALOPRAM 10 MG TABLET [Lexapro] 315 363 385 385 377 379 380
 380  380  
47335050944 ESOMEPRAZOLE SODIUM 40 MG VIAL [Nexium] 253 285        
62756050944 ESOMEPRAZOLE SODIUM 40 MG VIAL [Nexium] 285 302 292 296 296
 296  296  
00088222033 LANTUS 100U/ML VIAL 309 350 382 371 368 372 373
 373  373  
00456201001 LEXAPRO 10MG TABLET 92 55 45 26 12 12 12
 12  12  
00071015523 LIPITOR 10MG TABLET 68 43 30 21 20 20 20
 20  20  
00186504054 NEXIUM 40MG CAPSULE 198 211 206 98 25 33 33
 33  33  
00378022893 PIOGLITAZONE HCL 30 MG TABLET [Actos] 310 364 394 385 377 379 380
 380  380  
63653117105 PLAVIX 75MG TABLET 109 48 34 20 13 13 13
 13  13  
47335090288 QUETIAPINE FUMARATE 25 MG TAB [SEROQUEL] 316 364 394 385 377 379 380
 380  380  
00591207539 RISEDRONATE SODIUM 35 MG TABLET [Actonel] 243        
00093309844 RISEDRONATE SODIUM 35 MG TABLET [Actonel] 220 246 227 229 230
 230  230  
47335066868 RISEDRONATE SODIUM 35 MG TABLET [Actonel] 223 237 244 245
 245  245  
00310027510 SEROQUEL 25MG TABLET 112 54 43 26 12 12 12
 12  12  
00378632205 VALSARTAN-HCTZ 160-12.5 MG TAB [Diovan HCT] 297 343 388 376 370 372 373
 373  373  

*The formulary counts include both stand-alone prescription drug plans (PDP) and Medicare Advantage plans (MAPD) in all states and the U.S. territories.
**Ending 2013 CMS formulary dataset dated October, 2013. Ending 2014 CMS formulary dataset dated September, 2014. Ending 2015 CMS formulary dataset dated September, 2015. Ending 2016 CMS formulary dataset dated September, 2016. Starting 2017 CMS formulary dataset dated October, 2016 (Sanctioned plans not included in plan count).


You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your service area using our Q1Rx.com.







Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.